Adverse Events > 5% (Phase III)

%

Placebo 4 mg/d 4-12 mg/d 12 mg/d (n = 837) (n = 844) (n = 275) (n = 560)

Headache 21 21 17 23

Abdominal pain 18 20 22 19

Diarrhea 5 11 12 12

Nausea 9 9 8 10

Flatulence 7 8 8 7

Back pain 5 6 6 8

Influenza-like symptoms 6 7 4 8

Upper respiratory tract infections 8 6 10 5

Dyspepsia 6 6 7 6

Dizziness 6 6 3 6

Pharyngitis 3 3 5 4

2

Previous slide

Next slide

Back to first slide

View graphic version